SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Martek Biosciences---- future biotech cash cow!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Saulamanca who wrote (200)1/15/2002 5:06:53 AM
From: Asymmetric  Read Replies (1) of 258
 
Jim, MATK got it's lift on Monday.

Up another 5.4% (+1.5). With trading volume WAY above
average, momentum says this stock is going higher and
that institutions are getting into stock. As you know
it often takes institutions many days, if not weeks, to
accumulate their positions...especially in a stock that
once saw an average daily trading volume of 80,000 shares.
However, manufacturing capacity constraints and relatively
low yields at present will put restraint on stock as far as
fundamental valuation. However, with Wall Street desperately
grasping for good growth stories, that may not matter, as
analysts shift investor focus to potential future markets
beyond infant formula to justify continued run-up in price...
along with the fact that many institutions and funds are
just learning about this company. Congrats.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News